Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercepharma.com
FiercePharma
Get the latest updates from FiercePharma directly as they happen.
Follow now 343 followers
Latest posts
Last updated about 4 hours ago
Trump selects surgeon and author Martin Makary for FDA commissioner post
about 19 hours ago
Trump selects surgeon and author Martin Makary for FDA commissioner post fkansteiner...
After FDA setbacks, Lexicon slashes commercial operations in transition back to clinical-stage outfit
about 22 hours ago
After FDA setbacks, Lexicon slashes commercial operations in transition back to clinical-stage...
As J&J tries to wrap up talc litigation in the US, the company now faces class action in UK
about 23 hours ago
As J&J tries to wrap up talc litigation in the US, the...
Calcium+Company enriches comms work with new commercial planning, market access division
about 23 hours ago
Calcium+Company enriches comms work with new commercial planning, market access division apark...
As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact
1 day ago
As other Big Pharmas face local headwinds, Pfizer doubles down on China...
Roche's Vabysmo shows potential to treat eye disorder common in Asia
1 day ago
Roche's Vabysmo shows potential to treat eye disorder common in Asia kdunleavy...
Meet 2024’s fiercest women in life sciences
2 days ago
Meet 2024’s fiercest women in life sciences aellison Thu, 11/21/2024 - 14:07
Fierce Pharma Asia—Big Pharma’s China layoffs, CSL's site closure and Kyowa Kirin's oncology deal
2 days ago
Fierce Pharma Asia—Big Pharma’s China layoffs, CSL's site closure and Kyowa Kirin's...
Trump leans toward selecting surgeon and COVID mandate critic Martin Makary for top FDA job: reports
2 days ago
Trump leans toward selecting surgeon and COVID mandate critic Martin Makary for...
Novartis, after slimming down, boosts growth projection through the end of the decade
2 days ago
Novartis, after slimming down, boosts growth projection through the end of the...
Biopharma status quo 'likely to persist' under Trump 2.0, though changes to IRA, FTC and more could be on the way: analyst
2 days ago
Biopharma status quo 'likely to persist' under Trump 2.0, though changes to...
Jazz's HER2 bispecific snags FDA nod, teeing up showdown with AZ and Daiichi's Enhertu
2 days ago
Jazz's HER2 bispecific snags FDA nod, teeing up showdown with AZ and...